D
32
10
AMAT
33
3
HBI
53
4
HPQ
55
3
IP
53
3
AON
25
4
JPM
59
6
NEM
30
2
JNPR
59
3
AIZ
61
5
LNC
28
3
PCG
59
9
SPG
45
2
CVS
27
2
LOW
42
14
DOV
48
2
CCI
30
2
AZO
46
3
ACN
54
2
ICE
53
5
D
32
10
AMAT
33
3
HBI
53
4
HPQ
55
3
IP
53
3
AON
25
4
JPM
59
6
NEM
30
2
JNPR
59
3
AIZ
61
5
LNC
28
3
PCG
59
9
SPG
45
2
CVS
27
2
LOW
42
14
DOV
48
2
CCI
30
2
AZO
46
3
ACN
54
2
ICE
53
5
Financhill
Back

Verona Pharma PLC Quote, Financials, Valuation and Earnings

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
42

VRNA
Verona Pharma PLC

Last Price:
$42.08
Seasonality Move:
-1.61%

7 Day Trial

ALL ACCESS PASS

$ 7

2025 Gold Forecast: A Perfect Storm for Demand

Discover our Gold Price Outlook for 2025--FREE--here

Verona Pharma PLC Price Quote

$42.08
+0.02 (+2.09%)
(Updated: December 21, 2024 at 5:53 AM ET)

Verona Pharma PLC Key Stats

Sell
42
Verona Pharma PLC (VRNA) is a Sell
Day range:
$40.10 - $42.86
52-week range:
$11.39 - $43.73
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
26.38%
Volume:
733.6K
Avg. volume:
1M
1-year change:
153.68%
Market cap:
$3.4B
Revenue:
$0
EPS:
$-2

How Much Does Verona Pharma PLC Make?

Data Unavailable

Is Verona Pharma PLC Growing As A Company?

Data Unavailable

Verona Pharma PLC Stock Price Performance

What Is Verona Pharma PLC 52-Week High & Low?

Verona Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verona Pharma PLC?

Data Unavailable

Is Verona Pharma PLC Cash Flow Positive?

Data Unavailable

Verona Pharma PLC Return On Invested Capital

Data Unavailable

Verona Pharma PLC Earnings Date & Stock Price

Verona Pharma PLC Competitors

  • Who Are Verona Pharma PLC's Competitors?
    Below is a list of companies who compete with Verona Pharma PLC or are related in some way:
    • Adaptimmune Therapeutics PLC (ADAP)
    • Autolus Therapeutics PLC (AUTL)
    • Biodexa Pharmaceuticals PLC (BDRX)
    • DBV Technologies SA (DBVT)
    • TC BioPharm (Holdings) PLC (TCBP)

Verona Pharma PLC Dividend Yield

Data Unavailable

Verona Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -36.59%
Revenue: 0% 180.53%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 47.29
Upside from Last Price: 12.42%

Major Shareholders

Data Unavailable